A comparison of viral immune escape strategies targeting the MHC class I assembly pathway

Immunological Reviews

Volumn 168, Issue , 1999, Pages 157-166

  Früh, Klaus ^a   Gruhler, Albrecht ^a   Krishna, Raman Murli ^a   Schoenhals, Gary J ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TAPASIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DNA VIRUS; ENDOPLASMIC RETICULUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; VIRUS IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIPORTERS; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULINS; MEMBRANE TRANSPORT PROTEINS; PEPTIDES; VIRAL PROTEINS; VIRUSES;

EID: 0033000015     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01290.x     Document Type: Review

References (76)

1. 1. Doherty P. Immunity to viruses. Immunologist 1995;3:231-233.
2. 2. Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996;8:478-483.
3. 3. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-624.
4. 4. Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature 1992;357:376-378.
5. 5. Früh K, Yang Y. Regulation of MHC class I antigen presentation by interferon γ. Curr Opin Immunol 1999;11:76-81.
6. 6. Beninga J, Rock KL, Goldberg AL. Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J Biol Chem 1998;273:18734-18742.
7. 7. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL. A proteolytic system that compensates for loss of proteasome function. Nature 1998;392:618-622.
8. 8. Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 1995;92:2479-2483.
9. 9. Garcia KC, et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996;384:577-581.
10. 10. Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 1992;357:342-345.
11. 11. Townsend A, Trowsdale J. The transporters associated with antigen presentation. Semin Cell Biol 1993;4:53-61.
12. 12. Neefjes JJ, Momburg F, Hämmerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993;261:769-771.
13. 13. Van Endert PM. Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing? Immunol Res 1996;15:265-279.
14. 14. Androlewicz MJ, Cresswell P. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1994;1:7-14
15. 15. Van Endert PM, et al. The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995;182:1883-1895.
16. 16. Momburg F, Neefjes JJ, Hämmerling GJ. Peptide selection by MHC-encoded TAP transporters. Curr Op Immunol 1994;6:32-37.
17. 17. Koopmann J-O, Post M, Neefjes JJ, Haemmerling GJ, Momburg F. Translocation of long peptides by transporters associated with antigen processing (TAP). Eur J Immunol 1996;26:1720-1728.
18. 18. Degen E, Williams DB. Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J Cell Biol 1991;112:1099-1115.
19. 19. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity I996;5:103-114.
20. 20. Morrice NA, Powis SA. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol 1998;8:713-716.
21. 21. Lindquist JA, Jensen ON, Mann M, Hämmerling GJ. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J 1998;17:2195-2195.
22. 22. Hughes E, Cresswell P. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide loading complex. Curr Biol 1998;8:709-712.
23. 23. Sadasivan BK, Cariappa A, Waneck GL, Cresswell P. Assembly, peptide loading, and transport of MHC class I molecules in a calnexin-negative cell line. Cold Spring Harb Symp Quant Biol 1995;60:267-275.
24. 24. Grandea A, III, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995;270:105-108.
25. 25. Ortmann B, et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 1997;277:1306-1309.
26. 26. Lehner PJ, Surman MJ, Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 1998;8:221-231.
27. 27. Jackson MR, Song ES, Young Y, Peterson PA. Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. Proc Natl Acad Sci USA 1992;89:12117-12121.
28. 28. Schoenhals GJ, et al. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J 1999;18:743-753.
29. 29. Peh CA, et al. HLA-B27-restricted antigen in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998;8:531-542.
30. 30. Niedermann G, et al. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J Exp Med 1997;186:209-220.
31. 31. Roizman B, Sears AE. Herpes simplex virus and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. Vol 2. Philadelphia, New York: Lippincott-Raven; 1996. p. 2231-2296.
32. 32. Chee MS, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990;154:125-169.
33. 33. Fish KN, Soderberg Naucler C, Mills LK, Stenglein S, Nelson JA. Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 1998;72:5661-5668.
34. 34. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-126.
35. 35. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998;95:3937-3942.
36. 36. Koszinowski UH, Reddehase MJ, Del Val M. Principles of cytomegalovirus antigen presentation in vitro and in vivo. Semin Immunol 1992;4:71-79.
37. 37. Gilbert MJ, Riddel SR, Plachter B, Greenberg PD. Cytomegalovirus selectivity blocks antigen processing and presentation of its immediate-early gene product. Nature 1996;383:720-722.
38. 38. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 1995;69:4830-4841.
39. 39. Ahn K, et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997;6:613-621.
40. 40. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus USII gene product dislocates MHC class I heavy chains from the ER to the cytosol. Cell 1996;84:769-779.
41. 41. Wiertz EJHJ, et al. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996;384:432-438.
42. 42. Maidji E, Tugizov S, Abenes G, Jones T. Pereira L. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F actin. J Virol 1998;72:5717-5727.
43. 43. Andersson M, Pääbo S, Nilsson T, Peterson PA. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 1985;43:215-222.
44. 44. Burgert HG, Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 1985;41:987-997.
45. 45. Nilsson T, Jackson M, Peterson PA. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 1989;58:707-718.
46. 46. Paabo S, Weber F, Nilsson T, Schaffner W, Peterson PA. Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J 1986;5:1921-1927.
47. 47. Cox JH, Bennink JR, Yewdell JW. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 1991;174:1629-1637.
48. 48. Jackson MR, Nilsson T, Peterson PA. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 1990;9:3153-3162.
49. 49. Cosson P, Letourneur F. Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 1994;263:1629-1631.
50. 50. Jackson MR, Nilsson T, Peterson PA. Retrieval of transmembrane proteins to the endoplasmic reticulum. J Cell Biol 1993;121:317-333.
51. 51. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 1996;93:10990-10995.
52. 52. Beersma MFC, Bijlmakers MJE, Ploegh H. Human cytomegalovirus downregulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993;151:4455-4464.
53. 53. Jones TR, Sun L. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 1997;71:2970-2979.
54. 54. Colberg-Poley AM, Santomenna LD, Harlow PP, Benfield PA, Tenney DJ. Human cytomegalovirus US3 and UL36-38 immediate early proteins regulate gene expression. J Virol 1992;66:95-105.
55. 55. Jones TR, Wiertz EJHJ, Sun L, Fish KN, Nelson JA, Ploegh HL. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 1996;93:11327-11333.
56. 56. Pahl HL, Sester M, Burgert H-G, Baeuerle PA. Activation of transcription factor NF-κB by the adenovirus E3/19K protein requires its ER retention. J Cell Biol 1996;132:511-522.
57. 57. Tenney DJ, Santomenna LD, Goudie KB, Colberg-Poley AM. The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression. Nucleic Acids Res 1993;21:2931-2937.
58. 58. Campbell JL, Schekman R. Selective packaging of cargo molecules into endoplasmic reticulum-derived COPII vesicles. Proc Natl Acad Sci USA 1997;94:837-842.
59. 59. Ziegler H, et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 1997;6:57-66.
60. + T lymphocytes. Cell 1994;77:525-535.
61. 61. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol 1994;152:2736-2741.
62. 62. Jackson MR, Früh K, Karlsson L, Teyton L, Yang Y, Peterson PA. Assembly and intracellular transport of MHC class I and class II molecules. Cold Spring Harb Symp Quant Biol 1995;60:249-261.
63. 63. Früh K, et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995;375:415-418.
64. 64. Hill A, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-415.
65. 65. Hughes EA, Hammond C, Cresswell P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci USA 1997;94:1896-1901.
66. 66. Tomazin R, et al. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 1998;72:2560-2563.
67. 67. Armandola EA, Momburg F, Nijenhuis M, Bulbuc N, Frueh K, Haemmerling GJ. A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur J Immunol 1996;26:1748-1785.
68. 68. Momburg F, Armandola EA, Post M, Haemmerling GJ. Residues in TAP2 peptide transporters controlling substrate specificity. J Immunol 1996;156:1756-1763.
69. 69. Ahn K, et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO J 1996;15:3247-3255.
70. 70. Tomazin R, et al. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 1996;15:3256-3266.
71. 71. Galocha B, et al. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2 terminal 35 residues. J Exp Med 1997;185:1565-1572.
72. 72. Lacaille VG, Androlewicz MJ. Herpes simplex virus inhibitor ICP47 destabilizes the transporter associated with antigen processing (TAP) heterodimer. J Biol Chem 1998;273:17386-17390.
73. 73. Hengel H, Flohr T, Haemmerling GJ, Koszinowski UH, Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J Gen Virol 1996;77:2287-2296.
74. 74. Hengel H, et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 1997;6:623-632.
75. 75. Lehner PJ, Karttunen JT, Wilkinson GWG, Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci USA 1997;94:6904-6909.
76. 76. Nijenhuis M, Hämmerling GJ. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J Immunol 1996;157:5467-5477.